Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
BCBSM, Inc. v. Vyera Pharmaceuticals, LLC et al
Case Number:
1:21-cv-01884
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 03, 2022
BCBS Unit's $28M Shkreli Deal Poised For Initial OK
A New York federal judge said she's ready to grant preliminary approval to a class action settlement calling for Martin Shkreli's former companies to pay up to $28 million to resolve antitrust claims from a Blue Cross unit.
-
December 10, 2021
Shkreli, Vyera To Settle Out Of BCBS Antitrust Class Action
Martin Shkreli, his former company and one of its executives told a New York federal court they have settled a private antitrust lawsuit from a Blue Cross unit, an expected move that came days after federal and state enforcers struck a similar deal with the companies minus the so-called "pharma bro."
-
May 06, 2021
Blue Cross Unit Wants To Lead If Shkreli Faces New Suits
A Blue Cross division has urged a New York federal judge to combine any future indirect buyers' suits against notorious drug industry figure Martin Shkreli for allegedly blocking a generic anti-parasitic medication with an existing Blue Cross suit and name Robins Kaplan as the plaintiffs' lead counsel.
-
March 04, 2021
'Pharma Bro' Shkreli Hit With 1st Private Antitrust Suit
Blue Cross and Blue Shield's Minnesota unit hit Martin Shkreli on Thursday with what appears to be the first proposed private antitrust class action against the incarcerated "pharma bro," following in the wake of a 2020 Federal Trade Commission case that made similar claims.